Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H‐2 associativity of variant‐specific antigens
- 1 January 1982
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 12 (11) , 905-908
- https://doi.org/10.1002/eji.1830121102
Abstract
By in vitro mutagenesis of mastocytoma P815, it is possible to obtain tumor cell variants that are rejected by syngeneic mice (tum−). Most of these variants carry new individual antigens and stimulate a specific cytolytic T cell (CTL) response in mixed leukocyte tumor cell culture (MLTC). The H-2 associativity of this response was examined for six different variants by measuring the inhibition of cell-mediated cytolysis by antibodies directed against products of the K or the D end of the H−2d complex. The lysis was either not inhibited (variants P91 and PI 16) or inhibited selectively by anti-Kd (variants P21, P32 and P198) or anti-Dd antibodies (variant P35). All these tum− variants expressed Kd and Dd antigens as measured by absorption of H-2 alloantisera. Long-term CTL clones can be obtained that are specific for individual turn antigens. The pattern of H-2 associativity obtained with MLTC-derived CTL against four tum− variants was verified with CTL clones directed against the specific antigens of these variants. Concordant results were observed in all cases. In addition to CTL clones specific for tum− antigens, it is possible to isolate clones against a P815 tumor-associated antigen found on all P815 tum− variants. For these clones no clear associativity with either Kd or Dd products was found.Keywords
This publication has 22 references indexed in Scilit:
- Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.The Journal of Experimental Medicine, 1980
- Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.The Journal of Experimental Medicine, 1980
- Inhibition of H-Y cell-mediated cytolysis by H-2Db antiserum.The Journal of Experimental Medicine, 1979
- Inhibition of killer‐target cell interaction by monoclonal anti‐H‐2 antibodiesEuropean Journal of Immunology, 1979
- Exclusive involvement of H-2D(b) or H-2K(d) product in the interaction between T-killer lymphocytes and syngeneic H-2(b) or H-2(d) viral lymphomasThe Journal of Experimental Medicine, 1977
- H–2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytesNature, 1976
- Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Confirmation of genetic control of response to trinitrophenyl-modified H-2 antigens by the use of anti-H-2 and anti-Ia antibodies.The Journal of Experimental Medicine, 1976
- Cell‐mediated cytotoxicity to trinitrophenyl‐modified syngeneic lymphocytesEuropean Journal of Immunology, 1974
- Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic systemNature, 1974
- SEROLOGICAL ANALYSIS OF A RECOMBINATION IN THE H-2 REGION OF THE MOUSETransplantation, 1966